Nörodejeneratif Hastalıkların Patogenezinde Toll benzeri Reseptörler ve Tedavi Potansiyelleri
Toll-like Receptors in Pathogenesis of Neurodegenerative Diseases and their Therapeutic Potential
DOI: 10.22541/au.170663596.67396514/v1
Toll-like Receptors in Pathogenesis of Neurodegenerative Diseases and their Therapeutic Potential
DOI: 10.22541/au.170663596.67396514/v1
Acupuncture therapy for Parkinson's disease: a case report demonstrating symptomatic improvement without medication.
DOI: 10.3389/fneur.2023.1330054PMID: 38348115
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?
DOI: 10.3390/ijms25031641PMID: 38338925
Comparing the efficacy of therapeutic Thai acupressure on plantar acupoints and laser cane therapy on freezing of gait in Parkinson's disease: a randomized non-inferiority trial.
DOI: 10.3389/fneur.2024.1327448PMID: 38348165
Therapeutic Potential of Natural Compounds from Herbs and Nutraceuticals in Alleviating Neurological Disorders: Targeting the Wnt Signaling Pathway.
DOI: 10.1021/acs.jafc.3c07536PMID: 38284360
Design, Synthesis and In Vitro Evaluation of Levodopa Stearic Acid Hydrazide Conjugate for the Management of Parkinson's DiseaseNovel Conjugate for Parkinson's Disease.
DOI: 10.1055/a-2234-9859PMID: 38286420
Distinct mechanisms underlying the therapeutic effects of low-molecular-weight heparin and chondroitin sulfate on Parkinson's disease.
DOI: 10.1016/j.ijbiomac.2024.129846PMID: 38296150
Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic <i>Drosophila melanogaster</i> models.
DOI: 10.1080/19336934.2024.2306687PMID: 38286464
Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics.
DOI: 10.1080/07391102.2024.2308764PMID: 38287492
CDNF and ER stress: Pharmacology and therapeutic possibilities.
DOI: 10.1016/j.pharmthera.2024.108594PMID: 38290651
New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy.
DOI: 10.1016/j.arr.2024.102209PMID: 38286334
Recombinant Antibody Fragments for Immunotherapy of Parkinson's Disease.
DOI: 10.1007/s40259-024-00646-5PMID: 38280078
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.